Cryo-Cell International, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Leases (Tables)

Leases (Tables)

9 Months Ended

Aug. 31, 2021

The following table presents the right-of-use asset and short-term and long-term lease liabilities amounts recorded on the consolidated balance sheets as of August 31, 2021:

	August 31, 2021		November 30, 2020
Assets
Operating lease right-of-use asset	$	992,346	$	299,089

Liabilities
Current portion of operating lease liabilities	$	306,817	$	275,570
Operating lease long term liabilities		690,347		23,632
Total lease liability	$	997,164	$	299,202

Summary of Maturity of the Company's Lease Liabilities

The maturity of the Company’s lease liabilities at August 31, 2021 were as follows:

	Future Operating
Fiscal Year Ending November 30,	Lease Payments
2021 (remaining 3 months)	$	82,545
2022		339,182
2023		313,996
2024		295,086
2025		24,590
Less: Imputed interest		(58,235	)
Present value of lease liabilities	$	997,164

Summary of Remaining Lease Term and Discount Rates

The remaining lease term and discount rates are as follows:

	August 31, 2021
Lease Term and Discount Rate
Remaining lease term (years)
Operating lease		3.3
Discount rate (percentage)
Operating lease		3.5	%

Summary of Supplemental Cash Flow Information Related to Leases

Supplemental cash flow information related to leases is as follows:

	Three Months Ended		Nine Months Ended
	August 31, 2021		August 31, 2021

Operating cash outflows from operating leases	$	82,545	$	229,675

	Three Months Ended		Nine Months Ended
	August 31, 2020		August 31, 2020

Operating cash outflows from operating leases	$	65,754	$	196,940